BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32153581)

  • 1. Demeclocycline Reduces the Growth of Human Brain Tumor-Initiating Cells: Direct Activity and Through Monocytes.
    Sarkar S; Li Y; Mirzaei R; Rawji KS; Poon CC; Wang J; Kumar M; Bose P; Yong VW
    Front Immunol; 2020; 11():272. PubMed ID: 32153581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells.
    Sarkar S; Döring A; Zemp FJ; Silva C; Lun X; Wang X; Kelly J; Hader W; Hamilton M; Mercier P; Dunn JF; Kinniburgh D; van Rooijen N; Robbins S; Forsyth P; Cairncross G; Weiss S; Yong VW
    Nat Neurosci; 2014 Jan; 17(1):46-55. PubMed ID: 24316889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of brain tumor growth by reactivating myeloid cells with niacin.
    Sarkar S; Yang R; Mirzaei R; Rawji K; Poon C; Mishra MK; Zemp FJ; Bose P; Kelly J; Dunn JF; Yong VW
    Sci Transl Med; 2020 Apr; 12(537):. PubMed ID: 32238578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia induces Gas1 expression in human brain tumor-initiating cells to reduce tumorigenecity.
    Sarkar S; Poon CC; Mirzaei R; Rawji KS; Hader W; Bose P; Kelly J; Dunn JF; Yong VW
    Sci Rep; 2018 Oct; 8(1):15286. PubMed ID: 30327548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells.
    Sarkar S; Zemp FJ; Senger D; Robbins SM; Yong VW
    Neuro Oncol; 2015 Aug; 17(8):1095-105. PubMed ID: 25646025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells.
    Lawn S; Krishna N; Pisklakova A; Qu X; Fenstermacher DA; Fournier M; Vrionis FD; Tran N; Chan JA; Kenchappa RS; Forsyth PA
    J Biol Chem; 2015 Feb; 290(6):3814-24. PubMed ID: 25538243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells.
    McKenzie BA; Zemp FJ; Pisklakova A; Narendran A; McFadden G; Lun X; Kenchappa RS; Kurz EU; Forsyth PA
    Neuro Oncol; 2015 Aug; 17(8):1086-94. PubMed ID: 25605818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors.
    Davis B; Shen Y; Poon CC; Luchman HA; Stechishin OD; Pontifex CS; Wu W; Kelly JJ; Blough MD;
    Neuro Oncol; 2016 Mar; 18(3):350-60. PubMed ID: 26245525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells.
    Sarkar S; Mirzaei R; Zemp FJ; Wei W; Senger DL; Robbins SM; Yong VW
    Cancer Res; 2017 Jun; 77(12):3231-3243. PubMed ID: 28416488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI monitoring of monocytes to detect immune stimulating treatment response in brain tumor.
    Yang R; Sarkar S; Korchinski DJ; Wu Y; Yong VW; Dunn JF
    Neuro Oncol; 2017 Mar; 19(3):364-371. PubMed ID: 27571884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells.
    Grinshtein N; Rioseco CC; Marcellus R; Uehling D; Aman A; Lun X; Muto O; Podmore L; Lever J; Shen Y; Blough MD; Cairncross GJ; Robbins SM; Jones SJ; Marra MA; Al-Awar R; Senger DL; Kaplan DR
    Oncotarget; 2016 Sep; 7(37):59360-59376. PubMed ID: 27449082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
    Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
    Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The battle for the brain: Brain tumor-initiating cells vs. microglia/macrophages.
    Sarkar S; Yong VW
    Oncoimmunology; 2014; 3():e28047. PubMed ID: 25340004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ingramon, a Peptide Inhibitor of MCP-1 Chemokine, Reduces Migration of Blood Monocytes Stimulated by Glioma-Conditioned Medium.
    Krasnikova TL; Arefieva TI; Pylaeva EA; Sidorova MV
    Bull Exp Biol Med; 2016 Feb; 160(4):480-2. PubMed ID: 26906197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGL2-wired macrophages secrete CXCL7 to regulate the stem-like functionality of glioma cells.
    Yan J; Zhao Q; Wang J; Tian X; Wang J; Xia X; Ott M; Rao G; Heimberger AB; Li S
    Cancer Lett; 2021 May; 506():83-94. PubMed ID: 33676940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
    Manoranjan B; Wang X; Hallett RM; Venugopal C; Mack SC; McFarlane N; Nolte SM; Scheinemann K; Gunnarsson T; Hassell JA; Taylor MD; Lee C; Triscott J; Foster CM; Dunham C; Hawkins C; Dunn SE; Singh SK
    Stem Cells; 2013 Jul; 31(7):1266-77. PubMed ID: 23592496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors.
    Choi SA; Choi JW; Wang KC; Phi JH; Lee JY; Park KD; Eum D; Park SH; Kim IH; Kim SK
    Neuro Oncol; 2015 Jun; 17(6):810-21. PubMed ID: 25378634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma-associated circulating monocytes and the release of epidermal growth factor.
    Fries G; Perneczky A; Kempski O
    J Neurosurg; 1996 Oct; 85(4):642-7. PubMed ID: 8814168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.